Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/2124
Title: | Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI database. |
Epworth Authors: | Moon, Daniel |
Other Authors: | Sharma, Gopal Shah, Milap Ahluwalia, Puneet Dasgupta, Dasgupta Challacombe, Benjamin Bhandari, Mahendra Ahlawat, Rajesh Rawal, Sudhir Buffi, Nicolomaria Sivaraman, Ananthkrishnan Porter, James Rogers, Craig Mottrie, Alexandre Abaza, Ronney Ho Rha, Khoon Yuvaraja, Thyavihally Parekh, Dipen Capitanio, Umberto Maes, Kris Porpiglia, Francesco Turkeri, Levent Gautam, Gagan |
Keywords: | Partial Nephrectomy Propensity Matching Retroperitoneal Robot-Assisted Partial Nephrectomy RAPN Transperitoneal Robot-Assisted Partial Nephrectomy TRRAPN Vattikuti Collective Quality Initiative RENAL Nephrometry Scores Estimated Glomerular Filtration Rate Serum Creatinine Intraoperative Complications Epworth Prostate Centre, Epworth HealthCare, Victoria, Australia |
Issue Date: | Jul-2022 |
Publisher: | Springer |
Citation: | World J Urol . 2022 Jul 22 |
Abstract: | Objective: To compare perioperative outcomes following retroperitoneal (RPRAPN) and transperitoneal robot-assisted partial nephrectomy (TPRAPN). Methods: With this Vattikuti Collective Quality Initiative (VCQI) database, study propensity scores were calculated according to the surgical access (TPRAPN and RPRAPN) for the following independent variables, i.e., age, sex, side of the surgery, RENAL nephrometry scores (RNS), estimated glomerular filtration rate (eGFR) and serum creatinine. The study's primary outcome was the comparison of trifecta between the two groups. Results: In this study, 309 patients who underwent RPRAPN were matched with 309 patients who underwent TPRAPN. The two groups matched well for age, sex, tumor side, polar location of the tumor, RNS, preoperative creatinine and eGFR. Operative time and warm ischemia time were significantly shorter with RPRAPN. Intraoperative blood loss and need for blood transfusion were lower with RPRAPN. There was a significantly higher number of intraoperative complications with RPRAPN. However, there was no difference in the two groups for postoperative complications. Trifecta outcomes were better with RPRAPN (70.2% vs. 53%, p < 0.0001) compared to TPRAPN. We noted no significant change in overall results when controlled for tumor location (anteriorly or posteriorly). The surgical approach, tumor size and RNS were identified as independent predictors of trifecta on multivariate analysis. Conclusion: RPRAPN is associated with superior perioperative outcomes in well-selected patients compared to TPRAPN. However, the data for the retroperitoneal approach were contributed by a few centers with greater experience with this technique, thus limiting the generalizability of the results of this study. |
URI: | http://hdl.handle.net/11434/2124 |
DOI: | 10.1007/s00345-022-04101-4 |
PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35867142/ |
ISSN: | 0724-4983 1433-8726 |
Journal Title: | World Journal of Urology |
Type: | Journal Article |
Affiliated Organisations: | Department of Urologic Oncology, Max Institute of Cancer Care, Saket, New Delhi, India. King's College, King's Health Partners, London, UK Guy's and St. Thomas' NHS Foundation Trust, London, UK Vattikuti Foundation, Detroit, MI, USA The Medicity Hospital, New Delhi, India. Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India Humanitas Research Hospital, Rozzano, MI, Italy. Chennai Urology and Robotics Institute, Chennai, India Swedish Medical Center, Seattle, WA, USA. Henry Ford Hospital, Detroit, MI, USA ORSI Academy, Melle, Belgium Central Ohio Urology Group, Mount Carmel Health System Prostate Cancer Program, Columbus, OH, USA Yonsei University Health System, Seoul, South Korea Peter MacCallum Hospital, University of Melbourne, Royal Melbourne Clinical School, Melbourne, Australia. Kokilaben Dhirubhai Ambani Hospital, Mumbai, India University of Miami Health System, Miami, FL, USA Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy Center for Robotic and Minimally Invasive Surgery, Hospital Da Luz, Luz Sáude, Portugal San Luigi Gonzaga Hospital of Orbassano, Turin, Italy Acıbadem M.A., Department of Urology, Aydınlar University, Altuzinade Hospital, Istanbul, Turkey Department of Urologic Oncology, Max Institute of Cancer Care, Saket, New Delhi, India |
Type of Clinical Study or Trial: | Comparative Study |
Appears in Collections: | Epworth Prostate Centre |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.